BTG to commercialise sleep disorder sensor:
This article was originally published in Clinica
Executive Summary
The international subsidiary of UK technology transfer company BTG is looking for a partner to commercialise a non-invasive monitor for respiratory disorders such as sleep apnoea and sudden infant death syndrome (SIDS). The monitor uses a fibre-optic coupler sensor which is placed on a person's pulse point. This allows a single sensor to detect heartbeat and respiration rate at the same time. A second sensor can be used to monitor blood pressure. To detect SIDS a single fibre-optic cable could be incorporated into a thin mattress, says BTG. Unlike most infant apnoea monitors, it would not need to be connected to the baby. Software associated with the sensor can identify changes in breathing while eliminating the effects of body movements.
You may also be interested in...
As Casgevy, Lyfgenia Launches Proceed, CRISPR And bluebird bio CEOs Reassure
The CEOs of bluebird bio and CRISPR Therapeutics hope to inspire investor confidence that their gene-based therapies for sickle cell disease and beta thalassemia will be widely reimbursed in the US and EU.
Japan Regulatory Update: Revised Law Widens RWD Scope, Price Revisions/Listings
Japan now allows pseudonymized personal data for medical use under a licensing system for wider use of real-world data. Meanwhile, a national cost-effectiveness assessment scheme has slashed reimbursement prices for Lagevrio and Kerendia, and Alexion’s Voydeya has been added to the reimbursement tariff.
Abbott's ‘Bedrock Of Good Health’ Nutritionals Business Faces Mounting Infant Formula Litigation
Nutritional product business had 5.1% Q1 sales growth and is like Abbott’s other segments, “super well-aligned to the global demographics and trends in health care,” says CEO Ford. But as it defends complaints of damages from powder formulas made at facility found with unsafe levels of bacterial contaminants, Abbott’s also targeted in litigation alleging failure to warn about risk of infants born prematurely developing necrotizing enterocolitis if fed cow’s milk-based formula.